|
|
|
|
|
Legal status
Patent expired
| (51) | INT.CL. | C07D 211/58 | (2006.01) |
| A61K 31/4468 | (2006.01) | ||
| A61P 25/00 | (2006.01) | ||
| A61P 7/02 | (2006.01) |
| (11) | Number of the document | 1794126 |
| (13) | Kind of document | T |
| (96) | European patent application number | 05805643.3 |
| Date of filing the European patent application | 2005-09-26 | |
| (97) | Date of publication of the European application | 2007-06-13 |
| (45) | Date of publication and mention of the grant of the patent | 2013-03-20 |
| (46) | Date of publication of the claims translation | 2013-07-25 |
| (86) | Number | PCT/US2005/034813 |
| Date | 2005-09-26 |
| (87) | Number | WO 2006/037043 |
| Date | 2006-04-06 |
| (30) | Number | Date | Country code |
| 614014 P | 2004-09-27 | US |
| (72) |
THYGESEN, Mikkel, DK
SCHLIENGER, Nathalie, DK
TOLF, Bo-ragnar, SE
ANDERSSON, Carl-magnus, A., SE
BLATTER, Fritz, CH
BERGHAUSEN, Jorg, DE
|
| (73) |
Acadia Pharmaceuticals Inc.,
12830 El Camino Real, Suite 400, San Diego, CA 92130,
US
|
| (74) |
Liudmila GERASIMOVIČ,
IĮ "Liudmila Gerasimovič, Patentinis patikėtinis", Vingrių g. 13-42, LT-01141 Vilnius,
LT
|
| (54) | N-(4-Fluorbenzil)-N-(1-metilpiperidin-4-il)-N`-(4-(2-metilpropiloksi)-fenilmetil)karbamido hemitartrato kristalinė forma |
| CRYSTALLINE FORM OF N-(4-FLUOROBENZYL)-N-(1-METHYLPIPERIDIN-4-YL)-N`-(4-(2-METHYLPROPYLOXY)PHENYLMETHYL)CARBAMIDE HEMI-TARTRATE |
| Payment date | Validity (years) | Amount | |
| 2024-09-02 | 347.00 EUR |